These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3859296)

  • 21. Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells.
    Jeannesson P; Trentesaux C; Nyoung MN; Mayeux P; Jacquot R; Jardillier JC
    Leukemia; 1991 Jan; 5(1):14-8. PubMed ID: 1847982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenic RAS genes impair erythroid differentiation of erythroleukaemia cells.
    Zaker F; Darley RL; al Sabah A; Burnett AK
    Leuk Res; 1997 Jul; 21(7):635-40. PubMed ID: 9301684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
    Schaefer A; Dahle M; Radenz G; Steinheider G; Marquardt H
    Leukemia; 1991 Feb; 5(2):95-100. PubMed ID: 2020200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of marker enzymes in the K562 erythroleukaemia cell line: no coordinate expression of red cell enzymes on induction of haemoglobin synthesis.
    Horton MA
    Biomed Pharmacother; 1982; 36(4):213-6. PubMed ID: 6819869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New designed HMBA agents as inducers of erythroleukemia cell differentiation.
    Wang H; Zhang S; Zhou J; Zhang J
    Chin Med Sci J; 2002 Mar; 17(1):27-31. PubMed ID: 12894881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of hyperthermia on the differentiation and growth of K562 erythroleukemic cell line.
    Goliaei B; Rafiei M; Soheili Z
    Leuk Res; 2004 Dec; 28(12):1323-8. PubMed ID: 15475074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new group of potent inducers of differentiation in murine erythroleukemia cells.
    Reuben RC; Wife RL; Breslow R; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1976 Mar; 73(3):862-6. PubMed ID: 1062798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of coproporphyrinogen oxidase and synthesis of hemoglobin in human erythroleukemia K562 cells.
    Taketani S; Furukawa T; Furuyama K
    Eur J Biochem; 2001 Mar; 268(6):1705-11. PubMed ID: 11248690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for distinction of the differentiation-inducing activities and cytostatic properties of 9-(2-phosphonylmethoxyethyl)adenine and a variety of differentiation-inducing agents in human erythroleukemia K562 cells.
    Hatse S; De Clercq E; Balzarini J
    Mol Pharmacol; 1996 Nov; 50(5):1231-42. PubMed ID: 8913355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture.
    Rovera G; O'Brien TG; Diamond L
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2894-8. PubMed ID: 268640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Butyramide and monobutyrin: growth inhibitory and differentiating agents.
    Lea MA; Xiao Q; Sadhukhan A; Sharma S; Newmark HL
    Anticancer Res; 1993; 13(1):145-9. PubMed ID: 8476205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
    Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
    Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
    Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of differentiation of human erythroleukaemic cell line K562 by hemin.
    Baliga BS; Mankad M; Shah AK; Mankad VN
    Cell Prolif; 1993 Nov; 26(6):519-29. PubMed ID: 9116119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation of hemoglobin accumulation and commitment during murine erythroleukemia cell differentiation by treatment with imidazole.
    Gusella JF; Tsiftsoglou AS; Volloch V; Weil SC; Neumann J; Housman DE
    J Cell Physiol; 1982 Oct; 113(1):179-85. PubMed ID: 6957412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL; Wu RT
    Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel aromatic-heterocyclic biphenyls as potent anti-leukemia agents.
    Dong J; Pan X; Wang J; Su P; Zhang L; Wei F; Zhang J
    Eur J Med Chem; 2015 Aug; 101():780-9. PubMed ID: 26231079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperthermia induces differentiation without apoptosis in permissive temperatures in human erythroleukaemia cells.
    Sharif-Khatibi L; Kariminia A; Khoei S; Goliaei B
    Int J Hyperthermia; 2007 Dec; 23(8):645-55. PubMed ID: 18097851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor imidazotetrazinones: prodrugs targeted to the major groove of DNA.
    Stevens MF
    Farmaco; 1991 Jan; 46(1 Suppl):147-59. PubMed ID: 1854402
    [No Abstract]   [Full Text] [Related]  

  • 40. Antitumour imidazotetrazines--XVI. Macromolecular alkylation by 3-substituted imidazotetrazinones.
    Bull VL; Tisdale MJ
    Biochem Pharmacol; 1987 Oct; 36(19):3215-20. PubMed ID: 2444229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.